Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Associated Banc-Corp
ASB
$5.92B
| $10.4M | ﹤0.01% |
427,044
+95,552
| +29% | +$2.15M |
|
1552
Lifestance Health
LFST
$4.55B
| $10.4M | ﹤0.01% |
2,008,865
+581,732
| +41% | +$3.49M |
|
|
OKLO
1553
PUT
Oklo
OKLO
$8.28B
| $10.4M | ﹤0.01% |
+185,200
| New | +$7.14M |
|
|
CHX
1554
DELISTED
ChampionX
CHX
| $10.3M | ﹤0.01% |
416,479
+75,082
| +22% | +$1.89M |
|
1555
Asbury Automotive
ABG
$3.78B
| $10.3M | ﹤0.01% |
43,366
+13,792
| +47% | +$3.15M |
|
1556
Abercrombie & Fitch
ANF
$5.27B
| $10.3M | ﹤0.01% |
124,787
+5,550
| +5% | +$421K |
|
1557
PUT
Intuit
INTU
$91.5B
| $10.3M | ﹤0.01% |
13,100
-10,900
| -45% | -$7.38M |
|
1558
Amdocs
DOX
$6.22B
| $10.3M | ﹤0.01% |
113,017
-92,604
| -45% | -$8.28M |
|
1559
CALL
Arcus Biosciences
RCUS
$3.66B
| $10.3M | ﹤0.01% |
+1,265,900
| New | +$10.8M |
|
1560
CALL
FedEx
FDX
$76.9B
| $10.3M | ﹤0.01% |
45,100
+3,100
| +7% | +$679K |
|
1561
Global Net Lease
GNL
$1.95B
| $10.2M | ﹤0.01% |
1,356,566
+175,163
| +15% | +$1.33M |
|
1562
State Street SPDR S&P Regional Banking ETF
KRE
$4.56B
| $10.2M | ﹤0.01% |
172,039
-234,582
| -58% | -$13.1M |
|
1563
iShares Russell 1000 Growth ETF
IWF
$127B
| $10.2M | ﹤0.01% |
96,100
+92,320
| +2,442% | +$8.83M |
|
1564
Moelis & Co
MC
$4.72B
| $10.2M | ﹤0.01% |
163,657
+30,630
| +23% | +$1.72M |
|
|
LNW
1565
DELISTED
Light & Wonder
LNW
| $10.2M | ﹤0.01% |
105,854
+39,963
| +61% | +$3.42M |
|
1566
Axsome Therapeutics
AXSM
$11.4B
| $10.2M | ﹤0.01% |
97,490
+45,620
| +88% | +$4.83M |
|
1567
Enpro
NPO
$7.04B
| $10.2M | ﹤0.01% |
53,113
-9,227
| -15% | -$1.58M |
|
1568
CALL
General Motors
GM
$77.2B
| $10.1M | ﹤0.01% |
206,200
-267,100
| -56% | -$12.7M |
|
1569
Advanced Energy
AEIS
$12.6B
| $10.1M | ﹤0.01% |
76,405
+23,650
| +45% | +$2.61M |
|
1570
Champion Homes
SKY
$5.05B
| $10.1M | ﹤0.01% |
161,643
+51,180
| +46% | +$3.98M |
|
1571
Scholar Rock
SRRK
$6.32B
| $10.1M | ﹤0.01% |
285,320
+128,949
| +82% | +$4.05M |
|
1572
Novanta
NOVT
$6.2B
| $10.1M | ﹤0.01% |
78,306
+23,972
| +44% | +$2.92M |
|
1573
XPO
XPO
$23.5B
| $10.1M | ﹤0.01% |
79,913
-5,793
| -7% | -$650K |
|
1574
Simpson Manufacturing
SSD
$8B
| $10.1M | ﹤0.01% |
64,903
+12,396
| +24% | +$1.92M |
|
1575
Teva Pharmaceuticals
TEVA
$42.1B
| $10.1M | ﹤0.01% |
600,014
-163,832
| -21% | -$2.64M |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.